B
6.03
-0.08 (-1.31%)
| Previous Close | 6.11 |
| Open | 6.11 |
| Volume | 518,066 |
| Avg. Volume (3M) | 237,158 |
| Market Cap | 317,364,352 |
| Price / Earnings (TTM) | 12.06 |
| Price / Earnings (Forward) | 9.96 |
| Price / Sales | 1.16 |
| 52 Weeks Range | |
| Earnings Date | 8 Aug 2024 |
| Profit Margin | 3.72% |
| Operating Margin (TTM) | 23.71% |
| Diluted EPS (TTM) | 0.290 |
| Quarterly Revenue Growth (YOY) | 12.80% |
| Quarterly Earnings Growth (YOY) | 42.10% |
| Current Ratio (MRQ) | 1.50 |
| Operating Cash Flow (TTM) | 39.83 M |
| Levered Free Cash Flow (TTM) | 37.61 M |
| Return on Assets (TTM) | 18.16% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Bullish |
| Medical Care Facilities (Global) | Mixed | Bullish | |
| Stock | Biote Corp. | Bullish | Bullish |
AIStockmoo Score
0.5
| Analyst Consensus | 3.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -0.5 |
| Average | 0.50 |
|
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 27.60% |
| % Held by Institutions | 64.61% |
| 52 Weeks Range | ||
| Median | 12.00 (99.01%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Craig-Hallum | 16 Dec 2024 | 12.00 (99.00%) | Buy | 6.39 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 12 Nov 2024 | Announcement | Biote Reports Third Quarter 2024 Financial Results |
| 29 Oct 2024 | Announcement | Biote Schedules Third Quarter 2024 Financial Results Release and Conference Call |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |